Person subject to the notification requirement
Position: Chief Executive Officer
Issuer:
LEI: 74370089ATTSNBXJVT29
Notification type: INITIAL NOTIFICATION
Reference number: 9324/4/6
____________________________________________
Transaction date: 2022-01-14
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: I 2021A
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme
Transaction details
(1): Volume: 20000 Unit price:
Aggregated transactions
(1): Volume: 20000 Volume weighted average price:
____________________________________________
Transaction date: 2022-01-14
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: I 2021B
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme
Transaction details
(1): Volume: 20000 Unit price:
Aggregated transactions
(1): Volume: 20000 Volume weighted average price:
____________________________________________
Transaction date: 2022-01-14
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: I 2021C
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme
Transaction details
(1): Volume: 20000 Unit price:
Aggregated transactions
(1): Volume: 20000 Volume weighted average price:
____________________________________________
Transaction date: 2022-01-14
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: I 2021D
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme
Transaction details
(1): Volume: 20000 Unit price:
Aggregated transactions
(1): Volume: 20000 Volume weighted average price:
____________________________________________
Transaction date: 2022-01-14
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: I 2021E
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme
Transaction details
(1): Volume: 20000 Unit price:
Aggregated transactions
(1): Volume: 20000 Volume weighted average price:
____________________________________________
Transaction date: 2022-01-14
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: II 2021A
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme
Transaction details
(1): Volume: 25000 Unit price:
Aggregated transactions
(1): Volume: 25000 Volume weighted average price:
____________________________________________
Transaction date: 2022-01-14
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: II 2021B
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme
Transaction details
(1): Volume: 25000 Unit price:
Aggregated transactions
(1): Volume: 25000 Volume weighted average price:
____________________________________________
Transaction date: 2022-01-14
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: II 2021C
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme
Transaction details
(1): Volume: 25000 Unit price:
Aggregated transactions
(1): Volume: 25000 Volume weighted average price:
____________________________________________
Transaction date: 2022-01-14
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: II 2021D
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme
Transaction details
(1): Volume: 25000 Unit price:
Aggregated transactions
(1): Volume: 25000 Volume weighted average price:
CEO
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com
https://news.cision.com/biohit-oyj/r/biohit-oyj---managers--transactions---siltala,c3487978
https://mb.cision.com/Main/18502/3487978/1521705.pdf
(c) 2022 Cision. All rights reserved., source